Everence Capital Management Inc Alkermes Plc. Transaction History
Everence Capital Management Inc
- $1.47 Billion
- Q1 2025
A detailed history of Everence Capital Management Inc transactions in Alkermes Plc. stock. As of the latest transaction made, Everence Capital Management Inc holds 9,540 shares of ALKS stock, worth $278,854. This represents 0.02% of its overall portfolio holdings.
Number of Shares
9,540
Previous 9,540
-0.0%
Holding current value
$278,854
Previous $274,000
14.96%
% of portfolio
0.02%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding ALKS
# of Institutions
409Shares Held
177MCall Options Held
229KPut Options Held
436K-
Black Rock Inc. New York, NY29.1MShares$851 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$532 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.8MShares$345 Million0.05% of portfolio
-
State Street Corp Boston, MA8.02MShares$235 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY6.88MShares$201 Million3.72% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.8B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...